Related Experiment Video
Updated: Feb 13, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Economic burden of neonatal sepsis in sub-Saharan Africa
Sylvia L Ranjeva1,2, Benjamin C Warf3,4, Steven J Schiff2,5
1Medical Scientist Training Program, Pritzker School of Medicine, and Department of Ecology & Evolution, University of Chicago, Chicago, Illinois, USA.
Insights
Neonatal sepsis in sub-Saharan Africa causes millions of disability-adjusted life years (DALYs) lost annually. This study estimates the economic burden of neonatal infections in the region, highlighting the need for improved prevention and treatment strategies.
Area of Science:
- Global Health
- Pediatrics
- Infectious Diseases
Background:
- Neonatal infections are a major cause of preventable deaths in newborns, particularly in sub-Saharan Africa (SSA).
- Achieving Sustainable Development Goal 3 for child health requires reducing neonatal mortality from infections in developing nations.
- Accurate data on the incidence and causes of neonatal sepsis in SSA are lacking.
Purpose of the Study:
- To estimate the economic burden of neonatal sepsis in sub-Saharan Africa.
- To quantify the disability-adjusted life years (DALYs) lost due to neonatal sepsis in SSA.
- To underscore the impact of neonatal infections on public health and the economy in SSA.
Main Methods:
- Utilized data from global health agencies and medical literature to assess population demographics, incidence, and disease burden of neonatal sepsis in SSA.
- Calculated disability-adjusted life years (DALYs) associated with neonatal sepsis treatment and prevention.
- Employed the value of a statistical life (VSL) methodology to estimate the economic burden of untreated neonatal sepsis.
Main Results:
- Neonatal sepsis results in an estimated annual loss of 5.29–8.73 million DALYs in SSA.
- The estimated annual economic burden ranges from $10 billion to $469 billion, based on VSL.
- These findings represent a conservative estimate of the true burden.
Conclusions:
- Neonatal sepsis imposes a significant public health and economic burden on SSA.
- More effective treatment and prevention strategies could substantially reduce mortality and morbidity.
- Increased investment is crucial for characterizing, diagnosing, preventing, and managing neonatal sepsis and its long-term effects in SSA.
Background And Significance:
The third Sustainable Development Goal for child health, which aims to end preventable deaths of newborns and children less than 5 years of age by 2030, cannot be met without substantial reduction of infection-specific neonatal mortality in the developing world. Neonatal infections are estimated to account for 26% of annual neonatal deaths, with mortality rates highest in sub-Saharan Africa (SSA). Reliable and comprehensive estimates of the incidence and aetiology surrounding neonatal sepsis in SSA remain incompletely available. We estimate the economic burden of neonatal sepsis in SSA.
Methods:
Data available through global health agencies and in the medical literature were used to determine population demographics in SSA, as well as to determine the incidence, disease burden, mortality and resulting disabilities associated with neonatal sepsis. The disability-adjusted life years (DALY) associated with successful treatment or prevention of neonatal sepsis in SSA for 1 year were calculated. The value of a statistical life (VSL) methodology was estimated to evaluate the economic burden of untreated neonatal sepsis in SSA.
Results:
We conservatively estimate that 5.29-8.73 million DALYs are lost annually in SSA due to neonatal sepsis. Corresponding VSL estimates predict an annual economic burden ranging from $10 billion to $469 billion.
Conclusions:
Our results highlight and quantify the scope of the public health and economic burden posed by neonatal sepsis in SSA. We quantify the substantial potential impact of more successful treatment and prevention strategies, and we highlight the need for greater investment in strategies to characterise, diagnose, prevent and manage neonatal sepsis and its long-term sequelae in SSA.
More Related Videos
Related Concept Videos
Threats to Biodiversity
Sustainable Development

